BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
BLFS on Nasdaq
Shares outstanding
47,970,593
Price per share
$24.18
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
48,107,711
Total reported value
$1,227,205,552
% of total 13F portfolios
0%
Share change
-1,632,179
Value change
-$40,341,774
Number of holders
188
Price from insider filings
$24.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 12% -11% $151,967,279 -$19,132,500 5,957,165 -11% Casdin Capital, LLC 15 Oct 2025
T. Rowe Price Investment Management, Inc. 11% +21% $125,272,324 +$22,586,973 5,180,824 +22% T. Rowe Price Investment Management, Inc. 31 Dec 2025

As of 30 Sep 2025, 188 institutional investors reported holding 48,107,711 shares of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS). This represents 100% of the company’s total 47,970,593 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Casdin Capital, LLC 14% 6,707,165 -13% 14% $171,099,779
BlackRock, Inc. 12% 5,600,498 +1.1% 0% $142,868,705
T. Rowe Price Investment Management, Inc. 8.5% 4,066,852 -4.2% 0.06% $103,746,000
Invesco Ltd. 7.5% 3,599,444 +0.52% 0.01% $91,821,818
VANGUARD GROUP INC 6.2% 2,967,518 +2.4% 0% $75,701,384
STATE STREET CORP 3% 1,456,565 +3.4% 0% $37,156,973
FRED ALGER MANAGEMENT, LLC 2.3% 1,108,922 -11% 0.11% $28,288,600
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.3% 1,097,352 -0.43% 0.01% $27,993,449
FMR LLC 2.1% 1,015,771 +32869% 0% $25,912,309
Rockefeller Capital Management L.P. 2.1% 1,010,129 -1.6% 0.05% $25,768,391
DIMENSIONAL FUND ADVISORS LP 2.1% 1,003,383 +2.1% 0.01% $25,592,378
GEODE CAPITAL MANAGEMENT, LLC 2% 952,338 +3.4% 0% $24,296,516
ROYAL BANK OF CANADA 1.9% 919,236 +16% 0% $23,450,000
AMERIPRISE FINANCIAL INC 1.9% 908,901 -16% 0.01% $23,186,064
PALISADE CAPITAL MANAGEMENT, LP 1.9% 908,440 -1.2% 0.63% $23,174,304
GENEVA CAPITAL MANAGEMENT LLC 1.9% 899,031 -0.3% 0.39% $22,934,283
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 1.3% 630,591 -1.2% 0.17% $16,086,376
Stephens Investment Management Group LLC 1.3% 608,814 +14% 0.2% $15,530,845
MORGAN STANLEY 1.2% 580,700 +11% 0% $14,813,662
GAGNON SECURITIES LLC 1.1% 535,757 -0.77% 2.7% $13,667,161
Voya Investment Management LLC 1% 497,254 -31% 0.01% $12,684,950
RAYMOND JAMES FINANCIAL INC 1% 480,438 -32% 0% $12,255,961
BANK OF AMERICA CORP /DE/ 1% 478,273 -29% 0% $12,200,745
ROYCE & ASSOCIATES LP 0.98% 471,929 -9.6% 0.12% $12,038,909
Curi Capital, LLC 0.9% 432,124 -3.6% 0.2% $11,023,477

Institutional Holders of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,607,663 $38,913,662 +$5,645,800 $24.18 17
2025 Q3 48,107,711 $1,227,205,552 -$40,341,774 $25.51 188
2025 Q2 49,891,551 $1,074,666,783 +$46,084,960 $21.54 193
2025 Q1 47,668,681 $1,088,709,787 +$20,128,650 $22.84 188
2024 Q4 46,805,037 $1,214,970,492 +$32,659,912 $25.96 179
2024 Q3 45,183,883 $1,131,731,644 -$35,206,285 $25.04 192
2024 Q2 46,568,224 $997,611,721 +$51,859,539 $21.43 163
2024 Q1 44,231,426 $820,259,959 -$19,111,916 $18.55 148
2023 Q4 213,944 $3,476,590 -$6,747,374 $16.25 2
2023 Q3 42,938,400 $593,049,235 +$31,922,333 $13.81 149
2023 Q2 40,181,945 $888,059,338 +$39,876,615 $22.10 153
2023 Q1 38,451,731 $836,163,596 +$17,223,500 $21.75 164
2022 Q4 37,831,478 $688,528,293 -$11,360,354 $18.20 158
2022 Q3 37,111,880 $844,354,408 +$38,765,368 $22.75 163
2022 Q2 31,401,698 $433,814,451 -$5,868,320 $13.81 140
2022 Q1 35,055,829 $796,774,817 -$8,233,576 $22.73 152
2021 Q4 34,700,455 $1,293,309,183 +$116,261,670 $37.27 161
2021 Q3 31,691,993 $1,341,737,104 +$152,078,388 $42.32 160
2021 Q2 27,974,679 $1,245,142,856 +$121,341,493 $44.51 130
2021 Q1 25,413,153 $914,856,392 +$45,085,583 $36.00 129
2020 Q4 24,230,710 $966,616,419 +$97,191,534 $39.89 123
2020 Q3 22,054,918 $638,257,936 +$215,947,828 $28.94 102
2020 Q2 14,835,498 $242,645,153 +$49,168,266 $16.35 80
2020 Q1 12,125,864 $115,194,176 +$10,152,448 $9.50 73
2019 Q4 10,288,873 $166,468,873 -$1,190,705 $16.18 78
2019 Q3 10,179,799 $169,241,845 +$21,493,576 $16.63 76
2019 Q2 8,980,039 $150,448,121 +$6,076,610 $16.95 71
2019 Q1 8,599,553 $153,847,483 +$19,590,647 $17.89 65
2018 Q4 7,525,099 $90,520,000 -$6,012,003 $12.03 52
2018 Q3 7,614,985 $132,922,337 +$55,037,316 $17.50 51
2018 Q2 4,545,796 $51,865,700 +$32,049,875 $11.41 45
2018 Q1 1,683,075 $8,619,000 -$151,375 $5.12 23
2017 Q4 1,709,367 $10,256,000 +$2,570,647 $6.00 26
2017 Q3 1,281,603 $7,322,000 +$5,379,767 $5.71 17
2017 Q2 339,708 $812,000 +$183,536 $2.40 7
2017 Q1 266,664 $556,000 +$91,185 $2.09 7
2016 Q4 265,967 $430,000 -$34,995 $1.61 10
2016 Q3 282,237 $518,000 -$124,584 $1.84 10
2016 Q2 381,436 $609,000 +$39,268 $1.60 9
2016 Q1 356,105 $652,000 +$41,793 $1.82 8
2015 Q4 338,248 $735,000 +$10,055 $2.19 6
2015 Q3 333,720 $706,000 +$92,512 $2.12 5
2015 Q2 290,217 $566,010 -$196,460 $1.95 5
2015 Q1 422,277 $681,008 -$330,000 $1.61 9
2014 Q4 623,246 $1,023,008 -$91,798 $1.64 7
2014 Q3 579,026 $1,216,311 +$667 $2.10 7
2014 Q2 577,558 $1,317,011 +$1,317,001 $2.28 7